Dose Escalation in Neoadjuvant Chemoradiotherapy for Rectal Cancer: Short-Term Efficacy and Toxicity of VMAT–SIB vs. 3D-CRT
Authors:
- Suzana Stojanovic-RundicSSSuzana Stojanovic-Rundic
- Mladen MarinkovicMMMladen Marinkovic
- Aleksandra StanojevicASAleksandra Stanojevic
- Dusica GavrilovicDGDusica Gavrilovic
- Radmila JankovicRJRadmila Jankovic
- Natasa MaksimovicNMNatasa Maksimovic
- Aleksandar TomasevicATAleksandar Tomasevic
- Predrag PetrasinovicPPPredrag Petrasinovic
- Sandra RadenkovicSRSandra Radenkovic
- Milena CavicMCMilena Cavic
Open Access
Abstract
Background and Objectives: The standard treatment for locally advanced rectal cancer (LARC) includes neoadjuvant chemoradiotherapy (nCRT), followed by surgery with or without adjuvant chemotherapy (CT). This study evaluated the efficacy and safety of dose-escalated radiotherapy (RT) using the volumetric modulated arc therapy–simultaneous integrated boost (VMAT–SIB) technique in patients with LARC compared to 3D conformal radiotherapy (3D-CRT). Materials and Methods: This study prospectively enrolled 75 patients with LARC. All patients received nCRT using VMAT–SIB, delivering a tumor dose (TD) of 54 Gy in 25 fractions, with concomitant CT following the 5-fluorouracil and leucovorin (5-FU–LV) protocol. To compare the treatment outcomes and toxicity associated with the increased RT dose, a retrospective cohort of 62 patients treated with the 3D-CRT technique was analyzed. The 3D-CRT group received a TD of 50.4 Gy in 28 fractions with the same CT. Outcomes, including pathological complete response (pCR), tumor regression grade (TRG), and sphincter preservation rates, were compared. Results: Among operated patients, the group treated with VMAT–SIB demonstrated improved rates of pCR (20.6% vs. 8.9%), with a statistically significant trend (p = 0.06). Sphincter-preserving surgeries were performed in 49 out of 63 operated patients (77.8%) in the VMAT–SIB group, compared to 35 out of 56 (62.5%) in the 3D-CRT group. Analysis of the definitive postoperative stage revealed a significantly higher prevalence of lower T categories (T0–2) (p < 0.01), negative N status (p < 0.05), and lower stages (I + II) (p < 0.05) in patients treated with the intensified RT approach. However, no significant differences in acute toxicity were observed. Conclusions: The implementation of intensified treatment with a higher dose using the VMAT–SIB technique demonstrated significant benefits in downsizing and downstaging compared to the standard treatment approach. These findings support its integration into clinical practice. However, further prospective, multi-center studies are needed to validate these results and assess long-term outcomes.Keywords
All Related Versions
Funding Information
- European Commission (101079217, 451-03-136/2025-03/200043)
- Ministry of Science, Technological Development and Innovation of the Republic of Serbia (101079217, 451-03-136/2025-03/200043)
This publication has 36 references indexed in Scilit:
- Prognostic Implications of Nodal Yield in Rectal Cancer After Neoadjuvant Therapy: Is Nodal Yield Still Relevant Post Neoadjuvant Therapy?Indian Journal of Surgery, 2021
- Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry studyThe Lancet, 2018
- Time to surgery and pathologic complete response after neoadjuvant chemoradiation in rectal cancer: A population study on 2094 patientsClinical and Translational Radiation Oncology, 2017
- Preoperative Chemoradiation With VMAT-SIB in Rectal Cancer: A Phase II StudyClinical Colorectal Cancer, 2017
- International consensus guidelines on Clinical Target Volume delineation in rectal cancerRadiotherapy and Oncology, 2016
- NRG Oncology Radiation Therapy Oncology Group 0822: A Phase 2 Study of Preoperative Chemoradiation Therapy Using Intensity Modulated Radiation Therapy in Combination With Capecitabine and Oxaliplatin for Patients With Locally Advanced Rectal CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2015
- Partial Pathologic Response and Nodal Status as Most Significant Prognostic Factors for Advanced Rectal Cancer Treated With Preoperative ChemoradiotherapyWorld Journal of Surgery, 2012
- Der ICRU-Report 83: Verordnung, Dokumentation und Kommunikation der fluenzmodulierten Photonenstrahlentherapie (IMRT)Strahlentherapie und Onkologie, 2012
- The relationship of pathologic tumor regression grade (TRG) and outcomes after preoperative therapy in rectal cancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2005
- Geometrical uncertainties, radiotherapy planning margins, and the ICRU-62 reportRadiotherapy and Oncology, 2002